|Announcement Title||Change - Announcement of Cessation|
|Announcement Subtitle||RESIGNATION OF CHIEF OPERATING OFFICER|
|Securities||OUE LIPPO HEALTHCARE LTD (OUE LIPPO HC)
|Date & Time of Broadcast||Nov 18, 2019 22:43|
|Submitted By||Mr. Yet Kum Meng
Chief Executive Officer and Executive Director
|Description||This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), in accordance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.
This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: email@example.com).
|Name of person||Dr. Tan Tiong Chin Louis|
|Is effective date of cessation known?||Yes|
|Effective date for cessation||Feb 4, 2020|
|Detailed reason(s) for cessation||Pursue other opportunities.
After having interviewed Dr. Tan Tiong Chin Louis and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that, save as disclosed in this announcement, there are no material reasons for the cessation of Dr. Tan Tiong Chin Louis as the Chief Operating Officer.
|Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?||No|
|Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?||No|
|Any other relevant information to be provided to shareholders of the listed issuer?||No|
|Date of appointment to current position||Jan 4, 2018|
|Does the AC have a minimum of 3 members (taking into account this cessation)?||Yes|
|Number of independent directors currently resident in Singapore (taking this account this cessation)||2|
|Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months||4|
|Job Title||Chief Operating Officer|
|Role and responsibilities||Dr. Tan Tiong Chin Louis manages and oversees the overall operations of the Group.|
|Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidaries||Nil.|
|Shareholdings interest in the listed issuer and its subsidaries?||Yes|
|Shareholding Details||Dr. Tan Tiong Chin Louis holds 9,874 ordinary shares in OUE Lippo Healthcare Limited.
|Past (for the last 5 years)||Sixtyone Pte. Ltd.|
|Present||OUELH Japan Management K.K.
Jiangsu Chang San Jiao Biomedical Co., Ltd.
Pun Hlaing International Hospital Limited
Yoma Siloam Hospital Pun Hlaing Limited